Definitive Contract 75A50119C00072

This is a $9,050,674.00 definitive cost-sharing contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Cytovale Inc., a self-certified small disadvantaged business. The contract is for advancing Cytovale's biophysical early sepsis diagnostic towards U.S. Food and Drug Administration (FDA) 510(k) clearance. This contract was awarded under a Broad Agency Announcement (BAA) from the Biomedical Advanced Research and Development Authority (BARDA) that sought proposals for the advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear, and pandemic influenza threats, including diagnostics. The BAA did not have a set-aside designation.